Dr. Lam is an Associate Clinical Professor and a clinical pharmacist with board certification in Pharmacotherapy and Geriatric Pharmacy. Besides teaching didactic courses for Doctor of Pharmacy program, she trains pharmacy residents and PharmD candidates to optimize therapy outcome at Winthrop University Hospital, Mineola, NY. She works with physicians to resolve complicated drug therapy issues among older adults. She provides medication therapy management and offer educational sessions on drug related topics to promote health in the community. Dr. Lam has a deep interest in engaging the public via community outreach programs. She is the recipient of St. John's University Academic Service Learning Mini Grants which involve students in some form of required community service that promotes public good and uses service as a means of understanding course concepts. Prior to joining St. John’s University, she served as a Clinical Instructor at University of North Carolina School of Pharmacy, Chapel Hill, NC. Dr. Lam has contributed to multiple therapeutic textbooks including Pharmacotherapy: a Pathophysiologic Approach, Pharmacotherapy Principles and Practice & Fundamentals of Geriatric Pharmacotherapy. She is also a regular contributor to PubMed indexed journals, including Cardiology in Review. In addition, she serves as a peer reviewer/consultant for professional journals and organizations.
Identifying, resolving and preventing drug-related problems among the elderly by collaborating with other healthcare professionals. Appropriate drug use, medication adherence and community outreach programs to minorities, under-served and elderly
Lam, S. (2015). A Protease-Activated Receptor Antagonist for the Prevention of Thrombotic Events. Cardiol Rev..
Lam, S. (2015). Discontinuation of memantine standard release and its impact on patient therapy. Consult Pharm.
Lam, S. (2015). Memantine standard tablet and extended-release dosing considerations: a pharmacokinetic analysis.. J Am Geriatr Soc. .
Lam, S. (2013). Apixaban: a new factor Xa inhibitor for stroke prevention in patients with nonvalvular atrial fibrillation. Cardiol Rev..
Lam, S. (2012). Linezolid-associated thrombocytopenia. Consult Pharm.
Lam, S. (2011). Azilsartan: a newly approved angiotensin II receptor blocker. Cardiol Rev..
Lam, S. (2010). Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for type 2 diabetes. Cardio Rev.
Lam, S. (2009). Aliskiren for the treatment of hypertension: an update.. Clin Med – Therapeutics.
Lam, S. (2008). Emerging therapies for the treatment of Helicobacter pylori infections. Ann Pharmacother .
Lam, S. (2008). Interferon-1b for the treatment of multiple sclerosis. Expert Opin Drug Metab Toxicol.
Lam, S. (2008). Strontium ranelate for the management of osteoporosis. . Consult Pharm.
Lam, S. (2007). Aliskiren: an oral renin inhibitor for the treatment of hypertension. Cardio Rev.
Lam, S. (2007). Pharmacotherapy for depression among older adults. NYJHP.
Lam, S. (2007). Varenicline: a selective 4 2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.. Cardio Rev.
Lam, S. (2006). Exenatide: a novel incretin mimetic agent for treating type 2 diabetes Mellitus. Cardio Rev.
Lam, S. (2003). Insulin glargine: a new once-daily basal insulin for the management of type 1 and type 2 diabetes mellitus.. Heart Dis.
Lam, S. (2015). Anemia and Preventive Therapy. In: Fundamentals of Geriatric Pharmacotherapy: An Evidence-Based Approach. American Society of Health-system Pharmacists.
Lam, S. (2014). Urinary Incontinence. In: Pharmacotherapy: A Pathophysiologic Approach. McGraw Hill.
Lam, S. (2010). Chapter 16: Immunology & Hematology.. In: Fundamentals of Geriatric Pharmacotherapy: An Evidence-Based Approach. American Society of Health-system Pharmacists.
Lam, S. (2010). Chapter 65: Urinary Incontinence. In: Pharmacotherapy: A Pathophysiologic Approach. McGraw.